SAMHSA recognizes the challenges posed by the current COVID-19 situation and is providing the following guidance and resources to assist individuals, providers, communities, and states across the country. SAMHSA stands ready to assist in any manner possible.
SAMHSA Resources and Information
Synar letter to the State Authority for Mental and Substance Use Disorders (PDF | 389 KB)
COVID-19 Emergency Response for Suicide Prevention Grants CLOSED
Guidance for Law Enforcement and First Responders Administering Naloxone (PDF | 117 KB)
Letter to Treatment Providers on PPE (PDF | 543 KB)
SAMHSA COVID-19 Funded Grants (PDF | 340 KB)
Intimate Partner Violence and Child Abuse Considerations During COVID-19 (PDF | 328 KB)
Emergency Grants to Address Mental and Substance Use Disorders During COVID-19 CLOSED
COVID-19 Information for SAMHSA Discretionary Grant Recipients
COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance (PDF | 168 KB)
TAP 34: Disaster Planning Handbook for Behavioral Health Treatment Programs
Considerations for Outpatient Mental and Substance Use Disorder Treatment Settings (PDF | 104 KB)
COVID-19: Interim Considerations for State Psychiatric Hospitals (PDF | 210 KB)
UPDATED: Training and Technical Assistance Related to COVID-19 (PDF | 572 KB)
Virtual Recovery Resources (PDF | 244 KB)
Tips For Social Distancing, Quarantine, And Isolation During An Infectious Disease Outbreak
Telework and DFWP Drug Testing During COVID-19
Guidance for OTPs
Opioid Treatment Program (OTP) Guidance (March 16, 2020) (PDF | 216 KB)
OTP Guidance for Patients Quarantined at Home with the Coronavirus (PDF | 160 KB)
Sample OTP COVID-19 FAQs (PDF | 341 KB)
Use of Telemedicine While Providing Medication-Assisted Treatment (PDF | 146 KB)
Additional Federal Guidance
NEW: FCC Eases Lifeline Enrollment Process To Qualifying Low-Income Consumers During Covid-19 Pandemic (Deadline: June 20)
DEA SAMHSA Buprenorphine Telemedicine (PDF | 209 KB)
The Notification of Enforcement Discretion on Telehealth Remote Communications
DEA Information on Telemedicine (PDF | 75 KB)
DEA Diversion Control Division COVID-19 Information